Keyphrases
Schizophrenia
100%
Neural Basis
100%
Atypical Antipsychotics
100%
Cognitive Impairment
66%
Functional Outcome
66%
5-HT1A Receptor
66%
5-HT1A Agonist
66%
Event-related Potentials
33%
Stress-induced
33%
Energy Metabolism
33%
Dopamine
33%
Patients with Schizophrenia
33%
Neural Network
33%
Recent Advances
33%
Psychosis
33%
Cognitive Deficits
33%
Novel Therapeutics
33%
Chronic Treatment
33%
Rat Model
33%
Glutamate
33%
Prefrontal Cortex
33%
γ-aminobutyric Acid
33%
Lactate
33%
Facilitative Effects
33%
Mood Disorders
33%
Risperidone
33%
Schizophrenia Models
33%
Clozapine
33%
Olanzapine
33%
Clinical Evidence
33%
Cognitive Enhancement
33%
Perospirone
33%
Tandospirone
33%
Lactate Production
33%
Blonanserin
33%
Electrophysiological Measures
33%
Lurasidone
33%
Psychotic Illness
33%
People with Schizophrenia
33%
5-HT Receptor Subtypes
33%
Quetiapine
33%
Serotonin (5-HT) Receptors
33%
Melperone
33%
Neuroscience
Cognitive Disorders
100%
Typical Antipsychotic
100%
Atypical Antipsychotic
100%
5-HT1A Receptor
66%
5-HT Receptor
66%
5-HT1A Agonists
66%
Serotonin
33%
Event-Related Potential
33%
Prefrontal Cortex
33%
Receptor Subtype
33%
Energy Metabolism
33%
Gamma-Aminobutyric Acid
33%
Glutamic Acid
33%
Mood Disorder
33%
Clozapine
33%
Neural Network
33%
Risperidone
33%
Olanzapine
33%
Psychoactive Drug
33%
Melperone
33%
Lurasidone
33%
Tandospirone
33%
Quetiapine
33%
Receptor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Atypical Antipsychotics
100%
Cognitive Defect
75%
Lactic Acid
50%
Serotonin 1A Agonist
50%
Disease
25%
Receptor Subtype
25%
4 Aminobutyric Acid
25%
Rat Model
25%
Glutamic Acid
25%
Serotonin
25%
Psychotropic Agent
25%
Olanzapine
25%
Risperidone
25%
Miconazole
25%
Clozapine
25%
Tandospirone
25%
Melperone
25%
Blonanserin
25%
Mood Disorder
25%
Lurasidone
25%
Perospirone
25%
Quetiapine
25%